GlassScriptPhysician profile
Jami Veal
NPI 1467531970
$3,457.73
in general payments reported to CMS, 2019-2025
24 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $180 · 2021: $487 · 2022: $536 · 2023: $759 · 2024: $500 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530 · Entertainment: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.38 |
| Entertainment | $105.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $824.54 | 2022-2025 | Durysta, Xen Glaucoma Treatment System, Ozurdex |
| Sight Sciences, INC. | $386.56 | 2019-2023 | Omni Surgical System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $375.38 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $309.87 | 2022-2025 | Acthar |
| Bausch & Lomb Americas INC. | $242.56 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Allergan, INC. | $222.45 | 2021 | |
| Novartis Pharmaceuticals Corporation | $169.04 | 2019-2023 | |
| Optos, INC. | $153.08 | 2020-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $152.20 | 2019-2024 | |
| Alcon Vision LLC | $139.11 | 2019-2021 | |
| Oyster Point Pharma, INC. | $127.59 | 2022-2024 | Tyrvaya, Ryzumvi |
| Shire North American Group INC | $80.91 | 2019 | |
| Rayner Intraocular Lenses Limited | $73.04 | 2022-2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Glaukos Corporation | $32.17 | 2020-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Kala Pharmaceuticals, INC. | $25.96 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $21.64 | 2024 | Vevye |
| Rxsight INC | $17.44 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Sun Pharmaceutical Industries INC. | $17.05 | 2022 | |
| Eyepoint US, INC. | $15.42 | 2019 | |
| Aerie Pharmaceuticals, INC. | $15.27 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.10 | 2019 | |
| Omeros Corporation | $14.56 | 2021 | |
| Eyevance Pharmaceuticals LLC | $13.81 | 2019 | |
| Vyera Pharmaceuticals, LLC | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jami Veal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.